Effects of HMGB1/TLR4 on secretion IL-10 and VEGF in human jaw bone-marrow mesenchymal stem cells
DOI:
https://doi.org/10.1590/1678-7757-2023-0304%20Keywords:
HMGB1, JBMSCs, TLR4, IL-10, VEGF, Peri-implantitisAbstract
Objective: We aimed to investigate the regulatory effects of HMGB1/TLR4 signaling pathway on the expression of IL-10 and VEGF in human bone marrow mesenchymal stem cells. Methodology: Human JBMSCs were isolated and cultured. Then, HMGB1 was added into the JBMSCs culture medium, and the protein and mRNA expression levels of IL-10 and VEGF were assessed. Moreover, cells were pretreated with a specific TLR4 inhibitor (TAK-242), and the expression changes of IL-10 and VEGF were compared. Results: Compared with the control group, exposure to HMGB1 in human JBMSCs up-regulated TLR4, IL-10, and VEGF secretion at both protein and mRNA levels (P<0. 05). In addition, the increased expression of IL-10 and VEGF could be restrained in TAK-242 group compared with the HMGB1 group (P<0.05). Conclusions: The results indicated that HMGB1 activate TLR4 signaling pathway in Human JBMSCs, which plays a regulatory role in cytokines expression.
Downloads
References
He SJ, Cheng J, Feng X, Yu Y, Tian L, Huang Q. The dual role and therapeutic potential of high-mobility group box 1 in cancer. Oncotarget.
;8(38):64534-50. doi: 10.18632/oncotarget.17885
Ge Y, Huang M, Yao YM. The effect and regulatory mechanism of high mobility group Box-1 protein on immune cells in inflammatory diseases. Cells. 2021;10(5):1044. doi: 10.3390/cells10051044
Charoonpatrapong K, Shah R, Robling AG, Alvarez M, Clapp DW, Chen S, et al. HMGB1 expression and release by bone cells. J Cell
Physiol. 2006;207(2):480-90. doi: 10.1002/jcp.20577
Müller S, Ronfani L, Bianchi ME. Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine
function. J Intern Med. 2004;255(3):332-43. doi: 10.1111/j.1365-2796.2003.01296.x
Li L, Lu YQ. The regulatory role of high-mobility group protein 1 in sepsis-related immunity. Front Immunol. 2021;11:601815. doi: 10.3389/fimmu.2020.601815
Mohamed ME, Abduldaium YS, Younis NS. Ameliorative effect of linalool in cisplatin-induced nephrotoxicity: the role of HMGB1/TLR4/
NF-κB and NRF2/HO1 pathways. Biomolecules. 2020;10(11):1488. doi: 10.3390/biom10111488
Yasinska IM, Silva IG, Sakhnevych SS, Ruegg L, Hussain R, Siligardi G, et al. High mobility group box 1 (HMGB1) acts as an “alarmin” to
promote acute myeloid leukaemia progression. Oncoimmunology. 2018;7(6):e1438109. doi: 10.1080/2162402X.2018.1438109.
Wang M, Gauthier A, Daley LA, Dial K, Wu J, Woo J, et al. The Role of HMGB1, a nuclear damage-associated molecular pattern molecule, in the pathogenesis of lung diseases. Antioxid Redox Signal. 2019;31(13):954-93. doi: 10.1089/ars.2019.7818
Paudel YN, Angelopoulou E, Piperi C, Balasubramaniam VR, Othman I, Shaikh MF. Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling. Eur J Pharmacol. 2019;858:172487. doi: 10.1016/j.ejphar.2019.172487
Albrektsson T, Dahlin C, Jemt T, Sennerby L, Turri A, Wennerberg A. Is marginal bone loss around oral implants the result of a provoked
foreign body reaction? Clin Implant Dent Relat Res. 2014;16(2):155-65. doi: 10.1111/cid.12142
Li Z, Jiang CM, An S, Cheng Q, Huang YF, Wang YT, et al. Immunomodulatory properties of dental tissue-derived mesenchymal
stem cells. Oral Dis. 2014;20(1):25-34. doi: 10.1111/odi.12086
Cao C, Tarlé S, Kaigler D. Characterization of the immunomodulatory properties of alveolar bone-derived mesenchymal stem cells. Stem Cell Res Ther. 2020;11(1):102. doi: 10.1186/s13287-020-01605-x
Akintoye SO. The distinctive jaw and alveolar bone regeneration. Oral Dis. 2018;24(1-2):49-51. doi: 10.1111/odi.12761
Nakajima R, Ono M, Hara ES, Oida Y, Shinkawa S, Pham HT, et al. Mesenchymal stem/progenitor cell isolation from tooth
extraction sockets. J Dent Res. 2014;93(11):1133-40. doi: 10.1177/0022034514549377
Abduljabbar T, Vohra F, Ullah A, Alhamoudi N, Khan J, Javed F. Relationship between self-rated pain and peri-implant clinical,
radiographic and whole salivary inflammatory markers among patients with and without peri-implantitis. Clin Implant Dent Relat Res.
;21(6):1218-24. doi: 10.1111/cid.12866
Neumann C, Scheffold A, Rutz S. Functions and regulation of T cell-derived interleukin-10. Semin Immunol. 2019;44:101344. doi:
1016/j.smim.2019.10134417- Bellamri N, Viel R, Morzadec C, Lecureur V, Joannes A, de Latour B, et al. TNF-α and IL-10 Control CXCL13 Expression in Human Macrophages. J Immunol. 2020;204(9):2492-502. doi: 10.4049/jimmunol.1900790
Chloe P, Viviane M, Maria A, Diana A, Stephen H, Laura K, et al. Molecular Pharmacology of VEGF-A isoforms: binding and signalling at
VEGFR2. Int J Mol Sci. 2018;19(4):1264. doi: 10.3390/ijms19041264
Chen R, Lee C, Lin X, Zhao C, Li X. Novel function of VEGF-B as an antioxidant and therapeutic implications. Pharmacol Res. 2019;143:33-
doi: 10.1016/j.phrs.2019.03.002
Meng X, Chen M, Su W, Tao X, Sun M, Zou X, et al. The differentiation of mesenchymal stem cells to vascular cells regulated by the HMGB1/
RAGE axis: its application in cell therapy for transplant arteriosclerosis. Stem Cell Res Ther. 2018;9(1):85. doi: 10.1186/s13287-018-0827-z
Akintoye SO, Boyce AM, Collins MT. Dental perspectives in fibrous dysplasia and McCune-Albright syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116(3):e149-55. doi: 10.1016/j.oooo.2013.05.023
Du Y, Jiang F, Liang Y, Wang Y, Zhou W, Pan Y, et al. The angiogenic variation of skeletal site-specific human BMSCs from same alveolar
cleft patients: a comparative study. J Mol Histol. 2016;47(2):153-68. doi: 10.1007/s10735-016-9662-7
Li X, Zheng Y, Hou L, Zhou Z, Huang Y, Zhang Y, et al. Exosomes derived from maxillary BMSCs enhanced the osteogenesis in iliac
BMSCs. Oral Dis. 2020;26(1):131-44. doi: 10.1111/odi.13202
Davis HM, Valdez S, Gomez L, Malicky P, White FA, Subler MA, et al. High mobility group box 1 protein regulates osteoclastogenesis
through direct actions on osteocytes and osteoclasts in vitro. J Cell Biochem. 2019;120(10):16741-9. doi: 10.1002/jcb.28932
Teo Hansen Selnø A, Schlichtner S, Yasinska IM, Sakhnevych SS, Fiedler W, Wellbrock J, et al. High Mobility Group Box 1 (HMGB1) induces Toll-Like Receptor 4-mediated production of the immunosuppressive protein Galectin-9 in human cancer cells. Front Immunol. 2021;12:675731. doi: 10.3389/fimmu.2021.675731
Bangert A, Andrassy M, Müller AM, Bockstahler M, Fischer A, Volz CH, et al. Critical role of RAGE and HMGB1 in inflammatory heart
disease. Proc Natl Acad Sci U S A. 2016;113(2):E155-64. doi: 10.1073/pnas.1522288113
Fujita R, Tamai K, Aikawa E, Nimura K, Ishino S, Kikuchi Y, et al. Endogenous mesenchymal stromal cells in bone marrow are required
to preserve muscle function in mdx mice. Stem Cells. 2015;33(3):962-75. doi: 10.1002/stem.1900
Berglundh T, Armitage G, Araujo MG, Avila-Ortiz G, Blanco J, Camargo PM, et al. Peri-implant diseases and conditions: consensus
report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Clin
Periodontol. 2018;45 Suppl 20:S286-S291. doi: 10.1111/jcpe.12957
Derks J, Tomasi C. Peri-implant health and disease: a systematic review of current epidemiology. J Clin Periodontol. 2015;42 Suppl
:S158-71. doi: 10.1111/jcpe.12334DOI:10.1111/jcpe.12334
Renvert S, Lindahl C, Persson GR. Occurrence of cases with peri-implant mucositis or peri-implantitis in a 21-26 years follow-up study.
J Clin Periodontol. 2018;45(2):233-40. doi: 10.1111/jcpe.12822
Heitz-Mayfield LJA, Salvi GE, Mombelli A, Loup PJ, Heitz F, Kruger E, et al. Supportive peri-implant therapy following anti-infective surgical
peri-implantitis treatment: 5-year survival and success. Clin Oral Implants Res. 2018;29(1):1-6. doi: 10.1111/clr.12910
Carcuac O, Derks J, Abrahamsson I, Wennström JL, Berglundh T. Risk for recurrence of disease following surgical therapy of peri-implantitis: a prospective longitudinal study. Clin Oral Implants Res. 2020;31(11):1072-7. doi: 10.1111/clr.13653
Monje A, Pons R, Roccuzzo A, Salvi GE, Nart J. Reconstructive therapy for the management of peri-implantitis via submerged guided bone regeneration: a prospective case series. Clin Implant Dent Relat Res. 2020;22(3):342-50. doi: 10.1111/cid.12913.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Journal of Applied Oral Science
This work is licensed under a Creative Commons Attribution 4.0 International License.
Todo o conteúdo do periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons do tipo atribuição CC-BY.
